About IndiTreat® test
IndiTreat® is for cancer therapy selection
With IndiTreat®, you can test different panels of drugs and drug combinations on microtumors derived from individual patients to identify resistance and sensitivity.
Key benefits of IndiTreat
- Predict tumor resistance and sensitivity to cancer drugs
- Select the most appropriate treatment, in accordance with guidelines or off-label
- Improve patient quality of life through in vitro testing of drug efficacy on the individual patient
- Identify the most effective treatment in chemo-naïve colorectal cancer patients
- Identify the most effective treatment in late-stage colorectal cancer patients
- Complement the genomic characterisation of tumours with functional data on resistance and sensitivity to drugs
Want to know more?
Contact us
Please contact 2cureX for more information
Email: info@2cureX.com
Phone: +45 22115399
Web: www.IndiTreat.com
Upcoming events
February 10, 2021
VATOR SWISS NORDIC BIO 2021 – The Annual Nordic Healthcare Investor Summit in Zürich
